Advertisement
BME or MEDI or XLV
Which ETF would AI Choose? BlackRock Health Sciences Trust (BME) vs. Harbor Health Care ETF (MEDI) vs. Health Care Select Sector SPDR Fund (XLV)
Key Takeaways
- BlackRock Health Sciences Trust (BME) is a closed-end fund (CEF) focused on health sciences equities with an active management approach and higher expense ratio compared to the other two.
- Harbor Health Care ETF (MEDI) is an actively managed ETF targeting global health care companies with a concentrated portfolio of approximately 37 holdings and an expense ratio of 0.80%.
- Health Care Select Sector SPDR Fund (XLV) is a low-cost passive ETF tracking the health care sector of the S&P 500 Index, offering broad diversification across 63 holdings at an expense ratio of 0.08%.
- Structural differences include BME's closed-end structure with potential premium/discount dynamics, MEDI's active thematic tilt toward innovation-driven names, and XLV's market-cap weighted passive exposure to large-cap U.S. health care leaders.
- XLV provides the highest liquidity and lowest cost for broad sector exposure, while MEDI and BME introduce active selection risk and higher fees in pursuit of potential alpha within the health care theme.
- All three focus on the health care sector, but vary significantly in diversification depth, geographic reach, and sensitivity to large-cap pharmaceutical and biotechnology performance.
Introduction
These three funds offer distinct approaches to health care sector exposure, making them relevant for comparison in the current market environment. BlackRock Health Sciences Trust (BME) operates as a closed-end fund emphasizing health sciences, Harbor Health Care ETF (MEDI) delivers active global health care management, and Health Care Select Sector SPDR Fund (XLV) provides passive U.S. large-cap health care tracking. They do not track identical indexes but compete within the same broad sector, representing tiered strategies from active thematic to low-cost passive replication.
BlackRock Health Sciences Trust (BME) Overview
BlackRock Health Sciences Trust (BME) is a closed-end fund launched in 2005 with the objective of total return and income through long-term capital appreciation via equity securities of health sciences and related industries. It maintains an actively managed portfolio concentrated in health care companies, typically holding fewer positions than broad sector ETFs. Top holdings emphasize large pharmaceutical and biotechnology names. The fund features a higher expense ratio reflective of its active CEF structure and offers quarterly distributions. Distinguishing features include its closed-end format, which can lead to premium or discount trading relative to net asset value, and focus on health sciences innovation.
Harbor Health Care ETF (MEDI) Overview
Harbor Health Care ETF (MEDI) is an actively managed ETF launched in 2022 seeking long-term capital growth by investing in a narrow portfolio of global health care companies. It holds approximately 37 stocks, with significant allocations to pharmaceuticals and biotechnology innovators. Top holdings often include Eli Lilly and Company and Ascendis Pharma. The expense ratio stands at 0.80%. The strategy employs fundamental analysis to select quality businesses with differentiated products meeting valuation criteria. Key characteristics include its non-diversified nature, global exposure beyond the U.S., and higher turnover typical of active management.
Health Care Select Sector SPDR Fund (XLV) Overview
Health Care Select Sector SPDR Fund (XLV) is a passive ETF launched in 1998 that seeks to track the Health Care Select Sector Index, representing the health care component of the S&P 500. It holds 63 stocks, primarily U.S. large-cap companies across pharmaceuticals, health care equipment, providers, biotechnology, and life sciences. Top holdings are dominated by Eli Lilly, Johnson & Johnson, and AbbVie. The expense ratio is 0.08%. The fund employs a replication strategy with market-cap weighting and quarterly rebalancing aligned to the index. Distinguishing features include high liquidity, broad diversification within the S&P 500 health care universe, and low-cost exposure.
Industry and Thematic Landscape
The health care sector faces ongoing drivers including aging demographics, rising costs, innovation in biotechnology and pharmaceuticals, and shifts toward value-based care. Regulatory developments around drug pricing and approvals influence capital flows, while earnings growth in major holdings such as large-cap biopharma supports sector resilience. Macroeconomic factors like interest rates affect valuation multiples, and geopolitical tensions can impact global supply chains for medical devices and drugs. Recent market cycles highlight sensitivity to innovation pipelines and payer dynamics across developed markets.
Performance and Positioning Comparison
In recent months and market cycles, performance differences stem from structural variations. Health Care Select Sector SPDR Fund (XLV) has shown more stable trend consistency due to its broad, passive large-cap exposure, with lower volatility relative to active peers. Harbor Health Care ETF (MEDI) exhibits higher potential drawdowns from concentration in select innovators but may capture outsized gains during biotechnology rallies. BlackRock Health Sciences Trust (BME) displays distinct behavior influenced by its closed-end structure and active health sciences focus, often reflecting premium/discount fluctuations alongside underlying holdings. Relative positioning favors XLV for lower cost and diversification, while MEDI and BME offer differentiated active tilts at higher expense.
AI Screener
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Visit the AI Screener to explore current opportunities in health care and other sectors.
Tickeron AI Verdict
Based on observable structural strength, Tickeron’s AI would currently assign the highest probabilistic favor to Health Care Select Sector SPDR Fund (XLV) due to its superior cost efficiency, broad diversification across 63 holdings, high liquidity, and stable risk-adjusted positioning within the health care sector. The passive, low-expense framework provides consistent exposure with lower concentration risk compared to the active profiles of the other two funds.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
BME in upward trend: 10-day moving average crossed above 50-day moving average on October 22, 2026
The 10-day moving average for BME crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BME's RSI Oscillator exited the oversold zone, 26 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on BME as a result. In 58 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 72%.
The Moving Average Convergence Divergence (MACD) for BME just turned positive on October 14, 2026. Looking at past instances where BME's MACD turned positive, the stock continued to rise in 42 of 53 cases over the following month. The odds of a continued upward trend are 79%.
BME moved above its 50-day moving average on October 19, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.12% 3-day Advance, the price is estimated to grow further. Considering data from situations where BME advanced for three days, in 272 of 343 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BME declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
BME broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for BME entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
MEDI's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for MEDI turned positive on October 15, 2026. Looking at past instances where MEDI's MACD turned positive, the stock continued to rise in 44 of 48 cases over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on MEDI as a result. In 69 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 87%.
MEDI moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1.05% 3-day Advance, the price is estimated to grow further. Considering data from situations where MEDI advanced for three days, in 185 of 235 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MEDI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
MEDI broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for MEDI entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
XLV in upward trend: 10-day moving average crossed above 50-day moving average on October 15, 2026
The 10-day moving average for XLV crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on XLV as a result. In 77 of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.
The Moving Average Convergence Divergence (MACD) for XLV just turned positive on October 09, 2026. Looking at past instances where XLV's MACD turned positive, the stock continued to rise in 43 of 48 cases over the following month. The odds of a continued upward trend are 90%.
XLV moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where XLV advanced for three days, in 265 of 327 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The Aroon Indicator entered an Uptrend today. In 222 of 271 cases where XLV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 82%.
Bearish Trend Analysis
The 10-day RSI Indicator for XLV moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In 30 of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at 81%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XLV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
XLV broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
| BME | MEDI | XLV | |
|---|---|---|---|
| RSI ODDS (%) | 3 days ago 84% | N/A | 3 days ago 81% |
| Stochastic ODDS (%) | 3 days ago 75% | 3 days ago 76% | 3 days ago 77% |
| Momentum ODDS (%) | 3 days ago 72% | 3 days ago 87% | 3 days ago 79% |
| MACD ODDS (%) | 3 days ago 79% | 3 days ago 90% | 3 days ago 90% |
| TrendWeek ODDS (%) | 3 days ago 79% | 3 days ago 81% | 3 days ago 82% |
| TrendMonth ODDS (%) | 3 days ago 80% | 3 days ago 86% | 3 days ago 84% |
| Advances ODDS (%) | 5 days ago 79% | 4 days ago 79% | 11 days ago 81% |
| Declines ODDS (%) | 3 days ago 77% | 13 days ago 77% | 7 days ago 82% |
| BollingerBands ODDS (%) | 3 days ago 81% | 3 days ago 76% | 3 days ago 80% |
| Aroon ODDS (%) | 3 days ago 75% | 3 days ago 83% | 3 days ago 82% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FNGD | 28.15 | 0.19 | +0.68% |
| MicroSectors FANG+ Index - 3X Inverse Leveraged ETN (FNGD) | |||
| BLST | 24.58 | -0.03 | -0.13% |
| Bluemonte Short Term Bond ETF (BLST) | |||
| FPE | 16.89 | -0.03 | -0.18% |
| First Trust Preferred Securities & Income ETF (FPE) | |||
| OSCV | 40.33 | -0.12 | -0.31% |
| Opus Small Cap Value ETF (OSCV) | |||
| TAOZ | 89.48 | -0.69 | -0.76% |
| Thornburg American Opportunities Fund (TAOZ) | |||
How do my IRA Withdrawals Get Taxed During Retirement?
AI Pattern Search Engine (PSE): How to Use
What is PublicSq and How Did It Revolutionize E-commerce?
What Are Retained Earnings and Why Are They Important in Accounting?
What were the key factors contributing to the market's decline in the fall of 2008?
BME and
Correlation & Price change
A.I.dvisor tells us that BME and DHR have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BME and DHR's prices will move in lockstep.
| Ticker / NAME | Correlation To BME | 1D Price Change % | ||
|---|---|---|---|---|
| BME | 100% | -0.92% | ||
| DHR - BME | 16% Poorly correlated | +0.33% | ||
| UNH - BME | 12% Poorly correlated | -1.62% | ||
| ABBV - BME | 12% Poorly correlated | +0.16% | ||
| ABT - BME | 10% Poorly correlated | +1.16% | ||
| AMGN - BME | 9% Poorly correlated | -1.79% | ||
More | ||||
MEDI and
Correlation & Price change
A.I.dvisor indicates that over the last year, MEDI has been closely correlated with LLY. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if MEDI jumps, then LLY could also see price increases.
| Ticker / NAME | Correlation To MEDI | 1D Price Change % | ||
|---|---|---|---|---|
| MEDI | 100% | -0.97% | ||
| LLY - MEDI | 66% Closely correlated | -2.54% | ||
| ABBV - MEDI | 52% Loosely correlated | +0.16% | ||
| MRK - MEDI | 49% Loosely correlated | -1.34% | ||
| PFE - MEDI | 48% Loosely correlated | -1.28% | ||
| TECH - MEDI | 47% Loosely correlated | -0.10% | ||
More | ||||
XLV and
Correlation & Price change
A.I.dvisor indicates that over the last year, XLV has been closely correlated with LLY. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if XLV jumps, then LLY could also see price increases.